
Join to View Full Profile
1720 University BlvdBirmingham, AL 35233
Phone+1 630-945-7755
Dr. Tauscher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Robert Tauscher is an ophthalmologist based in Birmingham, AL, who graduated from Vanderbilt University School of Medicine in 2017. He has authored several publications in prominent journals such as the American Academy of Ophthalmology and the Journal of AAPOS. His recent works focus on topics including myopia progression, glaucoma development post-infantile cataract surgery, surgical doses for esotropia, optic disk drusen with papilledema, and ocular manifestations of vitiligo. His research contributes to the ongoing discourse in ophthalmology, with some of his work being cited by other professionals.
Education & Training
Vanderbilt University School of MedicineClass of 2017
Certifications & Licensure
AL State Medical License 2022 - 2026
NC State Medical License 2021 - 2023
IL State Medical License 2017 - 2021
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 3 citationsConcomitant optic disk drusen and papilledema due to idiopathic intracranial hypertension in a pediatric cohort.Mehdi Tavakoli, Florence Yan, Robert Tauscher
Journal of AAPOS. 2024-02-01 - 1 citationsDetermining relative thickness of inner retinal layers on single-line foveal optical coherence tomography (OCT) in healthy pediatric eyes-normative data for handheld OCT.Matthew L Haynie, Samuel Alvarez-Falcon, Robert Tauscher, Emma-Marie Taleb, Tanya Glaser
Journal of AAPOS. 2023-10-01 - 8 citationsOcular manifestations of vitiligo: a systematic review.Tessa LeWitt, Robert Tauscher, Gracious Obiofuma, Jonna Peterson, Ramez Haddadin
BMC Ophthalmology. 2023-03-27
Authored Content
- Amblyopia May Have a Genetic ComponentJuly 2025
- Ocular Side Effects of MEK Inhibitors Appear to Occur Infrequently in ChildrenMay 2025
- Efficacy and Safety Are Seen with Mydriatic Microdrops for ROP ScreeningMarch 2025
Press Mentions
Newsom Completes Phase 2 Clinical Trial of a Novel Drug for Pitt-Hopkins SyndromeJune 28th, 2024- Earlier Eye Patching May Be Beneficial for Children with Newly Diagnosed AmblyopiaJune 19th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









